May 25, 2013     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Nihon Nohyaku Receives Approval for Lanoconazole, Antifungal Agent for Athlete's Foot
 

Tokyo, Apr 26, 2006 (JCN) - Nihon Nohyaku has received approval for lanoconazole, its proprietary antifungal agent for treating athlete's foot and jockey itch, from the Ministry of Health, Labor and Welfare.

The new agent, which is based on the imidazole compound, has a broad spectrum and strong antifungal activity.

By Aki Tsukioka Contributor

Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Nihon Nohyaku Co., Ltd. News  
  Nihon Nohyaku Receives Approval for Lanoconazole, Antifungal Agent for Athlete's Foot  (Apr 26, 2006)
  Nihon Nohyaku Receives Approval for Lanoconazole, Antifungal Agent for Athlete's Foot  (Apr 26, 2006)
  Nihon Nohyaku to Set up New Representative Office in Shanghai  (May 31, 2005)
  Nihon Nohyaku Obtains Manufacturing Approval for Luliconazole Antifungal Agent  (Apr 13, 2005)
  Nihon Nohyaku to Acquire Mitsubishi Chemical's Agrochemical Division  (Aug 20, 2002)



 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Drugs & OTC news...

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Drugs & OTC news...

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Drugs & OTC news...

 Recent  Drugs & OTC News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Drugs & OTC news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)